Neonatology pp 369-374 | Cite as

Infants of Drug-Addicted Mothers

  • Eunji Kim
  • Gideon Koren


The wide variety of addictive substances share in common the reinforcing feature of individuals experiencing a persistent desire to administer the drugs and a strong obsession in obtaining them. Addiction to psychoactive substances is a complex issue, recognized as a class of mental disorders in the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) [1]. DSM-IV defines addiction as manifested by the compulsion to take a drug with a loss of control on the intake, and continued use despite knowledge of adverse physical and psychological health effects.


Attention Deficit Hyperactivity Disorder Biliary Atresia Prenatal Exposure Alcohol Exposure Fetal Alcohol Spectrum Disorder 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    American Psychiatric Association. (2000) Diagnostic and statistical manual of mental disorders, 4th edn., Text Revision. American Psychiatric Publishing, WashingtonGoogle Scholar
  2. 2.
    Araojo R, McCune S, Feibus K (2008) Substance abuse in pregnant women: making improved detection a good clinical outcome. Nature 83: 520–521Google Scholar
  3. 3.
    Morrison C, Siney C (1995) Maternity services for drug misusers in England and Wales: a national survey. Health Trends 27: 15–17PubMedGoogle Scholar
  4. 4.
    Hjerkinn B, Lindbaek M, Rosvold EO (2007) Substance abuse in pregnant women. Experiences from a special child welfare clinic in Norway. BMC Pub H 7: 322CrossRefGoogle Scholar
  5. 5.
    Bartu A, Sharp J, Ludlow J et al (2006) Postnatal home visiting for illict drug- using mothers and their infants: a randomised controlled trial. Aust N Z J Obstet Gynecol 46: 419–426CrossRefGoogle Scholar
  6. 6.
    World Health Organization (2009) Gender and women’s mental health Scholar
  7. 7.
    Nava-Ocampo AA, Velazquez-Armenta Y, Brien JF, Koren G (2004) Elimination kinetics of ethanol in pregnant women. Reprod Tox 18: 613–617CrossRefGoogle Scholar
  8. 8.
    Kapur BM, Vandenbroucke AC, Adamchik Y et al (2007) Formic acid, a novel metabolite of chronic ethanol abuse, causes neurotoxicity, which is prevented by folic acid. Alcohol Clin Exp Res 31: 2114–2120PubMedCrossRefGoogle Scholar
  9. 9.
    Lee RD, An SM, Kim SS et al (2005) Neurotoxic effects of alcohol and acetaldehyde during embryonic development. J Toxicol Environ Health A 10: 2147–2162CrossRefGoogle Scholar
  10. 10.
    Anderson DJ, Mondares RL, Born DE, Gleason CA (2008) The effect of binge fetal alcohol exposure on the number of vasoactive intestinal peptide-producing neurons in fetal sheep brain. Dev Neurosci 30: 276–284PubMedCrossRefGoogle Scholar
  11. 11.
    Kervern M, Dubois C, Naassila M et al (2008) Perinatal alcohol exposure in rat induces long-term depression of respiration after episodic hypoxia. Am J Respir Crit Care Med 179: 608–614PubMedCrossRefGoogle Scholar
  12. 12.
    Jones KL, Smith DW, Ulleland CN, Streissguth AP (1973) Pattern of malformation in offspring of chronic alcoholic mothers. Lancet 1: 1267–271PubMedCrossRefGoogle Scholar
  13. 13.
    May PH, Gossage JP (2001) Estimating the prevalence of fetal alcohol syndrome. A summary. Alcohol Res Health 25: 159–167PubMedGoogle Scholar
  14. 14.
    Koren G, Nulman I (2002) The Motherisk guide to diagnosing fetal alcohol spectrum disorder (FASD). Hospital for Sick Children, TorontoGoogle Scholar
  15. 15.
    Chudley AE, Conry J, Cook JL et al (2005) Fetal alcohol spectrum disorder: Canadian guidelines for diagnosis. CMAJ 172: S2–S21Google Scholar
  16. 16.
    Jones KL (1997) Smith’s recognizable patterns of human malformation, 5th edn. WB Saunders, PhiladelphiaGoogle Scholar
  17. 17.
    PS Cook (1990) Alcohol, tobacco and other drugs may harm the unborn, US Department of Health and Human Services. DHHS 90–1711Google Scholar
  18. 18.
    Windham GC, Von Behren J, Fenster L et al (1997). Moderate maternal alcohol consumption and risk of spontaneous abortion. Epidemiology, 8: 509–514PubMedCrossRefGoogle Scholar
  19. 19.
    Nash K, Rovet J, Greenbaum R et al (2006) Identifying the behavioral phenotype in fetal alcohol spectrum disorder: sensitivity, specificity and screening potential. Arch Womens Ment Health 9: 181–186PubMedCrossRefGoogle Scholar
  20. 20.
    Rasmussen C, Andrew G, Zwaigenbaum L, Tough S (2008) Neurobehavioral outcomes of children with fetal alcohol spectrum disorders: a Canadian perspective. Pediatr Child Health 13: 185–191Google Scholar
  21. 21.
    Sarkar M, Burnett M, Carriere S et al (2009) Screening and recording of alcohol use among women of child-bearing age and pregnant women. Can J Clin Pharmacol 17: 242–263Google Scholar
  22. 22.
    United Nations Office on Drugs and Crime (2008) 2008 World Drug Report. United Nations Publication, AustriaGoogle Scholar
  23. 23.
    Ebrahim SH, Gfroerer J (2003) Pregnancy-related substance use in the United States during 1996-1998. Obsete Gynecol 101: 374–379CrossRefGoogle Scholar
  24. 24.
    MacGregor SN, Sciarra JC, Keith L et al (1990) Prevalence of marijuana use during pregnancy. A pilot study. J Reprod Med 35: 1147–1149Google Scholar
  25. 25.
    Day NL, Richardson GA, Geva D et al (1994) Alcohol, marijuana, and tobacco: effects of prenatal exposure on offspring growth and morphology at age six. Alcohol Clin Exp Res 18: 786–794PubMedCrossRefGoogle Scholar
  26. 26.
    Zuckerman R (1989) Effects of maternal marijuana and cocaine use on fetal growth. N Eng J Med 320: 762–768CrossRefGoogle Scholar
  27. 27.
    Hatch EE, Bracken MB (1986) Effect of marijuana use in pregnancy on fetal growth. Am J Epidemiol 124: 986–993PubMedGoogle Scholar
  28. 28.
    English DR, Hulse GK, Mine E et al (1997) Maternal cannabis use and birth weight: a meta-analysis. Addiction 92: 1553–1560PubMedCrossRefGoogle Scholar
  29. 29.
    Fried PA (1989) Postnatal consequences of maternal marijuana use in humans. Ann NY Acad Sci 562: 123–132PubMedCrossRefGoogle Scholar
  30. 30.
    Huizink AC, Mulder EJ (2006) Maternal smoking, drinking or cannabis use during pregnancy and neurobehavioral and cognitive functioning in human offspring. Neuro Bio Rev 30: 24–41CrossRefGoogle Scholar
  31. 31.
    Fried PA, Smith AM (2001) A literature review of the consequences of prenatal marijuana exposure. An emerging theme of a deficiency in aspects of executive function. Neurotox Teratol 23: 1–11CrossRefGoogle Scholar
  32. 32.
    Webster WS, Brown-Woodman OD (1990) Cocaine as a cause of congenital malformations of vascular origin: experimental evidence in the rat. Teratol 41: 689–697CrossRefGoogle Scholar
  33. 33.
    Addis A, Moretti ME, Syed FA et al (2001) Fetal effects of cocaine: an updated meta-analysis. Reprod Toxicol 15: 341–369PubMedCrossRefGoogle Scholar
  34. 34.
    Cohen HR, Green JR, Crombleholme WR (1991) Peripartum cocaine use: estimating risk of adverse pregnancy outcome. Int J Gynecol Obstet 35: 51–54CrossRefGoogle Scholar
  35. 35.
    Handler A, Kristin N, Davis F, Ferre C (1991) Cocaine use during pregnancy: perinatal outcomes. Am J Epid 133: 818–825Google Scholar
  36. 36.
    Refuerzo JS, Sokol RJ, Blackwell SC et al (2002) Cocaine use and preterm premature rupture of membranes: improvement in neonatal outcome. Am J Obs Gynecol 186: 1150–1154CrossRefGoogle Scholar
  37. 37.
    Weathers WT, Crane MM, Sauvain KJ, Blackhurst DW (1993) Cocaine use in women from a defined population: prevalence at delivery and effects on growth in infants. Pediatrics 91: 350–354PubMedGoogle Scholar
  38. 38.
    Nulman I, Rovet J, Altmann D et al (1994) Neurodevelopment of adopted children exposed in utero to cocaine. Can Med Ass J 151: 1591–1597Google Scholar
  39. 39.
    Wasserman GA, Kline JK, Bateman DA et al (1998) Prenatal cocaine exposure and school-age intelligence. Drug Alcohol Depend 50: 203–210PubMedCrossRefGoogle Scholar
  40. 40.
    Lewis BA, Singer LT, Short EJ et al (2004) Four-year language outcomes of children exposed to cocaine in utero. Neurotox Teratol 26: 617–627CrossRefGoogle Scholar
  41. 41.
    Held JR, Riggs ML, Dorman C (1999) The effect of prenatal cocaine exposure on neurobehavioral outcome: a meta-analysis. Neurotox Teratol 21: 619–625CrossRefGoogle Scholar
  42. 42.
    Nora JJ, Vargo TA, Nora AH (1970) Dexamphetamine: a possible environmental trigger in cardiovascular malformations. Lancet 1: 1290–1291PubMedCrossRefGoogle Scholar
  43. 43.
    Levin JN (1971) Amphetamine ingestion in billiary atresia. J Ped 79: 130–131CrossRefGoogle Scholar
  44. 44.
    Milkovich L, Van den Berg BJ (1977) Effects of antenatal exposure to anorectic drugs. Am J Obstet Gynecol 129: 637–642PubMedGoogle Scholar
  45. 45.
    Little BB, Snell LM, Gilstrap LC (1988) Methamphetamine abuse during pregnancy: outcome and fetal effects. Obstet Gynecol 72: 541–544PubMedGoogle Scholar
  46. 46.
    Felix RJ, Chambers CD, Dick LM et al (2000) Prospective pregnancy outcome in women exposed to amphetamines. Teratology 61: 441Google Scholar
  47. 47.
    Smith L, Yonekura T, Wallace N et al (2003) Effects of prenatal methamphetamine exposure on fetal growth and drug withdrawal symptoms in infants born at term. J Dev Behav Pediatr 24: 17–24PubMedCrossRefGoogle Scholar
  48. 48.
    Chang LM, Smith C, LoPresti ML et al (2004) Smaller subcortical volumes and cognitive deficits in children with prenatal methamphetamine exposure. Psychiatry Res 132: 95–106PubMedCrossRefGoogle Scholar
  49. 49.
    McGuinness TM, Pollack D (2008) Parental methamphetamine abuse and children. J Pediatr Health Care 22: 152–158PubMedCrossRefGoogle Scholar
  50. 50.
    Lester BM, El Sohly M, Wright LL et al (2001) The maternal lifestyle study: drug use by meconium toxicology and maternal self-report. Pediatrics 107: 309–317PubMedCrossRefGoogle Scholar
  51. 51.
    Fajemirokun-Odudeyi O, Sinha C, Tutty S et al (2006) Pregnancy outcome in women who use opiates. Eur J Obstet Gynecol Reprod Biol 126: 170–175PubMedCrossRefGoogle Scholar
  52. 52.
    Ebner N, Rohrmeister J, Winklbaur B et al (2007) Management of neonatal abstinence syndrome in neonates born to opioid maintained women. Drug Alcohol Depend 87: 131–138PubMedCrossRefGoogle Scholar
  53. 53.
    Wilson GS, McCreary R, Kean J et al (1979) The development of preschool children of heroin-addicted mothers: a controlled study. Pediatrics 63: 135–141PubMedGoogle Scholar
  54. 54.
    Bunikowski R, Grimmer I, Heiser A et al (1998) Neurodevelopmental outcome after prenatal exposure to opiates. Eur J Pediatr 157: 724–730PubMedCrossRefGoogle Scholar
  55. 55.
    Kahan M, Wilson L (eds) (2002) Managing alcohol, tobacco and other drug problems: a pocket guide for physicians and nurses. Centre for Addiction and Mental Health, TorontoGoogle Scholar
  56. 56.
    Bertollini R, Kallen B, Mastroiacovo P et al (1987) Anticonvulsant drugs in monotherapy. Effect on the fetus. Eur J Epidemiol 3: 164–171PubMedCrossRefGoogle Scholar
  57. 57.
    Kjaer D, Horvath-Puho E, Christensen J et al (2007) Use of phenytoin, phenobarbital, or diazepam during pregnancy and risk of congenital abnormalities: a case-time control study. Pharmacoepidemiol Drug Saf 16: 181–188PubMedCrossRefGoogle Scholar
  58. 58.
    Coupey SM (1997) Barbiturates. Ped Rev 18: 260–264CrossRefGoogle Scholar
  59. 59.
    Dolovich LR, Addis A, Vaillancourt JM et al (1998) Benzodiazepine use in pregnancy and major malformations or oral cleft: metaanalysis of cohort and case-control studies. BMJ 317: 839–843PubMedCrossRefGoogle Scholar
  60. 60.
    Wikner BN, Stiller CO, Bergman U et al (2007) Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcomes and congenital malformations. Pharmacoepidemiol Drug Saf 11: 1203–1210CrossRefGoogle Scholar
  61. 61.
    McElhatton PR, Bateman DN, Evans C et al (1999) Congenital anomalies after prenatal ecstasy exposure. Lancet 354: 1441–1442PubMedCrossRefGoogle Scholar
  62. 62.
    Rodgers J, Ashton CH, Gilvarry E, Young AH (2004) Liquid ecstasy: a new kid on the dance floor. Br J Psychiatry 184: 104–106PubMedCrossRefGoogle Scholar
  63. 63.
    Abdel-Rahman MS, Ismail EE (2000) Teratogenic effect of ketamine and cocaine in CF-1 mice. Teratology 61: 291–296PubMedCrossRefGoogle Scholar
  64. 64.
    Maduska AL, Heighassermal M (1978) Arterial blood gases in mothers and infants during ketamine anesthesia for vaginal delivery. Anesth Analg 57: 121–123PubMedCrossRefGoogle Scholar
  65. 65.
    Chan CC, Fishman M, Egbert PR (1978) Multiple ocular anomalies associated with maternal LSD ingestion. Arch Ophthal 96: 282–284PubMedCrossRefGoogle Scholar
  66. 66.
    McGlothlin WH, Sparkes RS, Arnold DO (1970) Effect of LSD on human pregnancy. JAMA 212: 1483–1487PubMedCrossRefGoogle Scholar
  67. 67.
    Jones HE, Balster RL (1998) Inhalant abuse in pregnancy. Obst Gynecol Clin North Am 25: 153–167CrossRefGoogle Scholar
  68. 68.
    Havens JR, Simmons LA, Shannon LM et al (2009) Factors associated with substance use during pregnancy: results from a national sample. Drug Alcohol Depend 99: 89–95PubMedCrossRefGoogle Scholar
  69. 69.
    Draper JC, McCane-Katz EF (2005) Medical illness and comorbidities in drug users: implications for addiction pharmacotherapy treatment. Subst Use Misuse 40: 1899–1921PubMedCrossRefGoogle Scholar
  70. 70.
    Rubio DM, Kraemer KL, Max HF et al (2008) Factors associated with alcohol use, depression, and their co-occurrence during pregnancy. Alcoholism 32: 1543–1551PubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2012

Authors and Affiliations

  • Eunji Kim
  • Gideon Koren
    • 1
  1. 1.The Motherisk Program, Division of Clinical Pharmacology and ToxicologyThe Hospital for Sick ChildrenTorontoCanada

Personalised recommendations